HIV — SCE Infectious Diseases MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: D — Tenofovir Disoproxil/Emtricitabine/Dolutegravir
BHIVA 2025 pregnancy guidelines recommend commencing triple ART immediately with Tenofovir DF/Emtricitabine plus Dolutegravir 50 mg as the preferred regimen. Tenofovir DF is preferred over Tenofovir AF in pregnancy as the backbone NRTI due to greater pregnancy safety data, though TAF is an acceptable alternative. Dolutegravir is now the preferred integrase inhibitor in pregnancy following reassuring safety data regarding neural tube defects.
Reference: BHIVA 2025 – Guidelines on the management of HIV in pregnancy and the postpartum period